Sudarshan Pharma Reports 56% Profit Jump, Eyes ₹1,500 Cr Fundraising
Sudarshan Pharma Industries Ltd · 543828 · BSE ·
<b>Financials</b>: For FY26, Net Profit surged 56.2% to ₹23.4 Cr, and Revenue grew 39.2% to ₹703 Cr. Basic EPS increased to ₹0.97 (+56.5%). <b>Strategic Moves</b>: Acquired an API manufacturing facility in Telangana for ₹25.5 Cr and is actively pursuing a ₹1,500 Cr fundraising vi…